Skip to content
    Guidelines & Consensus

    Summary of the best evidence for whole-course nutritional management of bladder cancer

    Zhang et alFront Nutr

    An evidence synthesis and two-round Delphi expert consensus study established a structured framework for the whole-course nutritional management of patients with bladder cancer. Drawing from a comprehensive search across 11 electronic databases, 10 guideline websites, and 14 major professional society websites, the authors evaluated 16 eligible studies—comprising seven clinical guidelines, four evidence summaries, three expert consensus articles, one expert recommendation, and one clinical decision tool.
    From these sources, 91 evidence statements were extracted and synthesized across seven key clinical dimensions: nutrition team formation and management processes, three-tier nutritional diagnosis, principles of nutrition support therapy, content of nutritional interventions, nutritional surveillance, health education, and nutritional follow-up.
    Expert validation involved 17 experts in the first Delphi round and 15 in the second round, achieving an expert authority coefficient (Cr) of 0.88 for both rounds. Kendall's coefficients of concordance were 0.250 and 0.313 in the first and second rounds, respectively, confirming acceptable expert consensus. The resulting framework offers standardized, evidence-based guidance across treatment modalities and patient nutritional profiles, with clinical application for patients presenting with nutritional risk prior to or following radical cystectomy.

    Key Takeaways

    • A systematic review and Delphi consensus synthesized 91 evidence statements across seven clinical dimensions from 16 guidelines and consensus publications to form a whole-course nutritional management framework for bladder cancer.
    • Two rounds of Delphi consultation demonstrated high expert authority (Cr = 0.88) with Kendall's coefficients of concordance of 0.250 in round one and 0.313 in round two.
    • The synthesized framework supports evidence-based clinical guidance across bladder cancer treatment modalities, specifically targeting nutritional risk management in patients undergoing radical cystectomy.